Cargando…

Effective gene therapy for haemophilic mice with pathogenic factor IX antibodies

Formation of pathogenic antibodies is a major problem in replacement therapies for inherited protein deficiencies. For example, antibodies to coagulation factors (‘inhibitors’) seriously complicate treatment of haemophilia. While immune tolerance induction (ITI) protocols have been developed, inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markusic, David M, Hoffman, Brad E, Perrin, George Q, Nayak, Sushrusha, Wang, Xiaomei, LoDuca, Paul A, High, Katherine A, Herzog, Roland W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3840486/ https://www.ncbi.nlm.nih.gov/pubmed/24106230 http://dx.doi.org/10.1002/emmm.201302859

Ejemplares similares

Prevention and Reversal of Antibody Responses Against Factor IX in Gene Therapy for Hemophilia B
por: Nayak, Sushrusha, et al.
Publicado: (2011)

Tolerance Induction to Cytoplasmic β-Galactosidase by Hepatic AAV Gene Transfer — Implications for Antigen Presentation and Immunotoxicity
por: Martino, Ashley T., et al.
Publicado: (2009)

Operation in a Hæmophilic
Publicado: (1927)

A Hæmophilic Pedigree
por: Macnicol, Malcolm
Publicado: (1910)

Liver gene therapy by lentiviral vectors reverses anti-factor IX pre-existing immunity in haemophilic mice
por: Annoni, Andrea, et al.
Publicado: (2013)

Synovial Sarcoma Mimicking Haemophilic Pseudotumour
por: Mann, Haroon A., et al.
Publicado: (2006)

Clinical development of gene therapy: results and lessons from recent successes
por: Kumar, Sandeep RP, et al.
Publicado: (2016)

Haemophilic bleeding. Early management at home
Publicado: (1985)

Proteoglycan synthesis rate as a novel method to measure blood‐induced cartilage degeneration in non‐haemophilic and haemophilic rats
por: Pulles, Astrid E., et al.
Publicado: (2020)

Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia
por: Sarkar, Debalina, et al.
Publicado: (2014)

Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models
por: Markusic, David M., et al.
Publicado: (2017)

Intraarticular management of chronic haemophilic arthropathy (Review)
por: Poenaru, Daniela, et al.
Publicado: (2023)

Potential for cellular stress response to hepatic factor VIII expression from AAV vector
por: Zolotukhin, Irene, et al.
Publicado: (2016)

A Haemophilic Dengue Patient with Pleural Effusion and Earache
por: Das, Rajesh, et al.
Publicado: (2020)

Haemophilic Pelvic Pseudotumour: A New Surgical Option
por: Pasta, Gianluigi, et al.
Publicado: (2021)

Gene Therapy Research at the Frontiers of Viral Immunology
por: Hoffman, Brad E., et al.
Publicado: (2012)

Targeted approaches to induce immune tolerance for Pompe disease therapy
por: Doerfler, Phillip A, et al.
Publicado: (2016)

Gait Alteration Due to Haemophilic Arthropathies in Patients with Moderate Haemophilia
por: Fouasson-Chailloux, Alban, et al.
Publicado: (2022)

Molecular detection of haemophilic pathogens reveals evidence of Candidatus Mycoplasma haemobos in dogs and parasitic ticks in central China
por: Shi, Hongfei, et al.
Publicado: (2022)

Factor IX assay discrepancies in the setting of liver gene therapy using a hyperfunctional variant factor IX‐Padua
por: Robinson, Mary M., et al.
Publicado: (2021)

Proof of concept and feasibility of a blended physiotherapy intervention for persons with haemophilic arthropathy
por: Timmer, Merel A., et al.
Publicado: (2022)

Bilateral iliopsoas haemophilic “soft tissue pseudotumours”: A case report
por: Kamal, Achmad Fauzi, et al.
Publicado: (2015)

Postural Assessment Systems in the Prevention of Haemophilic Arthropathy: A Narrative Review
por: Scaturro, Dalila, et al.
Publicado: (2022)

Anti-Fas IgM monoclonal antibody (anti-Fas mAb) effect on haemophilic arthropathy (HA) synoviocytes
por: Guiducci, Serena, et al.
Publicado: (2012)

Life and Achievements of Professor Robert Gwyn Macfarlane, FRS: Pioneer in the Care of Haemophilics
por: Rizza, C R
Publicado: (1994)

ADAMTS‐4 as a possible distinguishing indicator between osteoarthritis and haemophilic arthropathy
por: Kalebota, Natasa, et al.
Publicado: (2022)

Thromboembolic Disease in Haemophilic Patients Undergoing Major Orthopaedic Surgery: Is Thromboprophylaxis Mandatory?
por: Badulescu, Oana Viola, et al.
Publicado: (2022)

180‐degree immersive VR motion visualization in the treatment of haemophilic ankle arthropathy
por: Ucero‐Lozano, Roberto, et al.
Publicado: (2022)

Immune responses to human factor IX in haemophilia B mice of different genetic backgrounds are distinct and modified by TLR4
por: Sack, B K, et al.
Publicado: (2015)

Coagulation factor IX gene transfer to non-human primates using engineered AAV3 capsid and hepatic optimized expression cassette
por: Kumar, Sandeep R.P., et al.
Publicado: (2021)

Effect of Neurodynamics Nerve Flossing on Femoral Neuropathy in Haemophilic Patients: A randomized controlled study
por: Hamed, Somaia A., et al.
Publicado: (2021)

Repeated autologous intraarticular blood injections as an animal model for joint pain in haemophilic arthropathy
por: Boettger, Michael Karl, et al.
Publicado: (2013)

The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
por: Agapidou, Alexandra, et al.
Publicado: (2016)

Clinical outcomes of arthroscopic synovectomy for adolescent or young adult patients with advanced haemophilic arthropathy
por: Zhang, Ting, et al.
Publicado: (2018)

Quality of life and its predictors among adult patients with haemophilic arthropathy. An observational study
por: Ucero-Lozano, Roberto, et al.
Publicado: (2021)

Immune Responses and Hypercoagulation in ERT for Pompe Disease Are Mutation and rhGAA Dose Dependent
por: Nayak, Sushrusha, et al.
Publicado: (2014)

Ankle joint distraction is a promising alternative treatment for patients with severe haemophilic ankle arthropathy
por: van Bergen, Eline D. P., et al.
Publicado: (2022)

Potential role of long non‐coding RNA H19 and Neat1 in haemophilic arthropathy
por: Sarangi, Pratiksha, et al.
Publicado: (2023)

Two years experience with low-dose recombined activated factor VII treatment of non-haemophilic patients
por: Michalska, G, et al.
Publicado: (2006)

On‐demand treatment with the iron chelator deferasirox is ineffective in preventing blood‐induced joint damage in haemophilic mice
por: Pulles, Astrid E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8u2hqia43ab2hqcmg3v2qvi9ki